Karacz CM, Yan J, Zhu H, Gerber DE. Timing, sites, and correlates of Lung Cancer recurrence. Clin Lung Cancer. 2020;21:127–e135123.
Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834–46.
Article PubMed PubMed Central Google Scholar
Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological principles of Metastasis. Cell. 2017;168:670–91.
Article PubMed PubMed Central Google Scholar
Giancotti Filippo G. Mechanisms governing metastatic dormancy and reactivation. Cell. 2013;155:750–64.
Article PubMed PubMed Central Google Scholar
Massagué J, Ganesh K. Metastasis-initiating cells and ecosystems. Cancer Discov. 2021;11:971–94.
Article PubMed PubMed Central Google Scholar
Puig I, Tenbaum SP, Chicote I, Arqués O, Martínez-Quintanilla J, Cuesta-Borrás E, Ramírez L, Gonzalo P, Soto A, Aguilar S, et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J Clin Invest. 2018;128:3887–905.
Article PubMed PubMed Central Google Scholar
Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Körbel C, Laschke MW, Gimotty PA, Philipp SE. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells. Cancer Cell. 2013;23:811–25.
Uzuner D, Akkoc Y, Peker N, Pir P, Gozuacik D, Cakir T. Transcriptional landscape of cellular networks reveal interactions driving the dormancy mechanisms in cancer. Sci Rep. 2021;11:15806.
Article PubMed PubMed Central Google Scholar
Torborg SR, Li Z, Chan JE, Tammela T. Cellular and molecular mechanisms of plasticity in cancer. Trends Cancer. 2022;8:735–46.
Article PubMed PubMed Central Google Scholar
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Reviews Clin Oncol. 2018;15:81–94.
Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20:398–411.
Agudo J, Aguirre-Ghiso JA, Bhatia M, Chodosh LA, Correia AL, Klein CA. Targeting cancer cell dormancy. Nat Rev Cancer. 2024;24:97–104.
Yeh AC, Ramaswamy S. Mechanisms of cancer cell dormancy—another hallmark of cancer? Cancer Res. 2015;75:5014–22.
Article PubMed PubMed Central Google Scholar
Holmgren L, O’reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149–53.
Kudaravalli S, den Hollander P, Mani SA. Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene. 2022;41:3177–85.
Article PubMed PubMed Central Google Scholar
Urra H, Dufey E, Avril T, Chevet E, Hetz C. Endoplasmic reticulum stress and the hallmarks of cancer. Trends cancer. 2016;2:252–62.
Qiu G-Z, Jin M-Z, Dai J-X, Sun W, Feng J-H, Jin W-L. Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies. Trends Pharmacol Sci. 2017;38:669–86.
Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun. 2015;6:6139.
Bakhoum SF, Ngo B, Laughney AM, Cavallo J-A, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TB, Taunk NK. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467–72.
Article PubMed PubMed Central Google Scholar
Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J cancer Res 2017;7:1016.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
Article PubMed PubMed Central Google Scholar
Ye X, Weinberg RA. Epithelial–mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25:675–86.
Article PubMed PubMed Central Google Scholar
Patel P, Chen EI. Cancer stem cells, tumor dormancy, and metastasis. Front Endocrinol. 2012;3:125.
Knott SR, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, Turgeon M-O, Fish L, Erard N, Gable AL. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 2018;554:378–81.
Article PubMed PubMed Central Google Scholar
Nieto MA, Huang RY-J, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21–45.
Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463–8.
Katsuno Y, Lamouille S, Derynck R. TGF-β signaling and epithelial–mesenchymal transition in cancer progression. Curr Opin Oncol. 2013;25:76–84.
Craene BD, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97–110.
Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275–92.
Article PubMed PubMed Central Google Scholar
Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175–80.
Article PubMed PubMed Central Google Scholar
Bockhorn M, Jain RK, Munn LL. Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 2007;8:444–8.
Article PubMed PubMed Central Google Scholar
Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proceedings of the National Academy of Sciences 2012, 109:13515–13520.
Wong AD, Searson PC. Mitosis-mediated intravasation in a tissue-engineered tumor–microvessel platform. Cancer Res. 2017;77:6453–61.
Article PubMed PubMed Central Google Scholar
Denais CM, Gilbert RM, Isermann P, McGregor AL, Te Lindert M, Weigelin B, Davidson PM, Friedl P, Wolf K, Lammerding J. Nuclear envelope rupture and repair during cancer cell migration. Science. 2016;352:353–8.
Article PubMed PubMed Central Google Scholar
Chothia C, Jones EY. The molecular structure of cell adhesion molecules. Annu Rev Biochem. 1997;66:823–62.
Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533–48.
留言 (0)